GLOPID-R

CEPI

Vaccine manufacturability focused on speed

CEPI has announced a new funding opportunity for the development of vaccine manufacturability focused on speed.

This Call for Proposals asks for the submission of a proposal for manufacturability-related innovations and technologies that can accelerate the time required to make clinical trial material or CTM for emergency use, in response to a new pathogen outbreak.

Read the full request for proposal

  • Application deadline: December 15, 2023
Back to Resources
EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094188.